PRGO- Perrigo Company plc
Healthcare · Drug Manufacturers - Specialty & Generic
Price & Performance
Performance
Analysis & Verdict
Analyst Ratings
Wall Street consensus from 4 analysts
12-Month Price Target
$16.50
Based on analyst estimates; price targets are opinions, not guarantees.
Fair Value Estimates
Current price: $13.65
Graham Number
√(22.5 × EPS × Book Value)
N/A
Benjamin Graham's intrinsic value formula. Assumes a fair stock trades at no more than 22.5× the product of EPS and book value per share.
Bazin Ceiling Price
Avg. Annual DPS (5Y) ÷ 6%
$16.89
Décio Bazin's dividend-based ceiling. The max price you should pay so that dividends alone deliver at least 6% annual yield on your cost basis.
These are simplified estimates. Not financial advice.
Buy & Hold Checklist
Quality criteria for long-term holding
5/10
56% score
Pays dividends
15Y hist.15+ years of dividend history
Dividend consistency (5Y+)
15 yrsUninterrupted dividend payments for at least 5 years
ROE above 10%
-48.7%Return on equity - measures how efficiently capital is used
Positive profit margin
-41.9%Net profit margin must be positive - company earns more than it spends
Revenue growth (annual)
-3.2%Annual revenue must be growing compared to the prior year
Earnings growth (annual)
Annual earnings must be growing compared to the prior year
Debt/Equity below 2×
138.18×Low financial leverage reduces risk of distress
Current ratio above 1
2.32×Short-term assets must cover short-term liabilities
Daily liquidity above $5M
$44M/dayHigh trading volume ensures easy entry and exit
Dividend yield above 0%
8.49%Stock must distribute income to shareholders
Financials
Revenue & Results
Key Statistics
Earnings
Next Earnings
Nov 4, 2026
50
days
EPS (TTM)
$-12.29
P/E (TTM)
-
Fwd P/E
5.7
SEC Filings & Reported Financials
Earnings History
SEC EDGAR · official filings
SEC Filings
Official EDGAR documents
Insider Transactions
SEC Form 4 · officers, directors & 10% owners
Dividends & Income
Dividends
Current DY
8.49%
5Y Avg Annual
$0.9952
Last Payment
$0.2900
Ex-Date
08/28/2026
Annual dividends paid per share
| Ex-Date | Payment | Amount | Est. DY |
|---|---|---|---|
Latest08/28/2026 | 09/15/2026 | $0.2900 | 8.50% |
05/29/2026 | 06/16/2026 | $0.2900 | 8.50% |
03/02/2026 | 03/20/2026 | $0.2900 | 8.50% |
08/29/2025 | 09/16/2025 | $0.2900 | 8.50% |
05/30/2025 | 06/17/2025 | $0.2900 | 8.50% |
03/07/2025 | 03/25/2025 | $0.2900 | 8.50% |
11/29/2024 | 12/17/2024 | $0.2760 | 8.09% |
08/30/2024 | 09/17/2024 | $0.2760 | 8.09% |
Magic Number
Shares needed to self-fund your next purchase
$13.65
Price
$0.2900
Last div. (semesterly)
48
shares
Own 48 PRGO shares ($655.20) and each semesterly dividend pays for 1 new share - the snowball runs on its own.
Investment target
$655.20
New shares / year
+2 shares
Dividend Calculator
8.50% yieldEstimate PRGO dividend income at the current rate.
Per year
$849.82
Per month
$70.82
≈ 732.6 shares at $1.16/share a year. Estimate only - dividends can be cut or raised.
Tools & Simulators
PRGO vs Peers, Indexes & Commodities
?Click a card below to plot it on the chart
Loading history…
Parameters
Final value
$426,404.61
Total invested
$130,000.00
Total interest
$296,404.61
Balance over time
Period breakdown
| Period | Balance | Invested | Interest |
|---|---|---|---|
| Start | $10,000.00 | $10,000.00 | $0.00 |
| Year 1 | $17,270.27 | $16,000.00 | $1,270.27 |
| Year 2 | $25,267.56 | $22,000.00 | $3,267.56 |
| Year 3 | $34,064.59 | $28,000.00 | $6,064.59 |
| Year 4 | $43,741.32 | $34,000.00 | $9,741.32 |
| Year 5 | $54,385.72 | $40,000.00 | $14,385.72 |
| Year 6 | $66,094.55 | $46,000.00 | $20,094.55 |
| Year 7 | $78,974.28 | $52,000.00 | $26,974.28 |
| Year 8 | $93,141.97 | $58,000.00 | $35,141.97 |
| Year 9 | $108,726.44 | $64,000.00 | $44,726.44 |
| Year 10 | $125,869.35 | $70,000.00 | $55,869.35 |
| Year 11 | $144,726.56 | $76,000.00 | $68,726.56 |
| Year 12 | $165,469.48 | $82,000.00 | $83,469.48 |
| Year 13 | $188,286.70 | $88,000.00 | $100,286.70 |
| Year 14 | $213,385.63 | $94,000.00 | $119,385.63 |
| Year 15 | $240,994.47 | $100,000.00 | $140,994.47 |
| Year 16 | $271,364.18 | $106,000.00 | $165,364.18 |
| Year 17 | $304,770.87 | $112,000.00 | $192,770.87 |
| Year 18 | $341,518.22 | $118,000.00 | $223,518.22 |
| Year 19 | $381,940.31 | $124,000.00 | $257,940.31 |
| Year 20 | $426,404.61 | $130,000.00 | $296,404.61 |
What is compound interest?
Compound interest means that the interest you earn in one period is added to your principal, so in the next period you earn interest on a larger base. This creates exponential growth: the longer your time horizon, the more dramatic the effect.
Which rate should I use?
The S&P 500 has historically returned ~10%/year before inflation over long periods - use this for an all-equity US index fund scenario. A balanced growth portfolio (stocks + bonds) is closer to 7%. High-yield savings accounts (HYSA) are currently paying around 4-5% with FDIC insurance and zero market risk. Bonds historically return ~4% annualized.
Formula used
FV = PV × (1+r)^n + PMT × ((1+r)^n − 1) / rwhere r is the monthly rate, n is the number of months, PV is the initial investment, and PMT is the monthly contribution. Annual rates are converted to monthly viar = (1 + annual%)^(1/12) − 1.
For educational purposes only. Not financial advice. Past returns do not guarantee future results.
Discussion
Sign in to join the discussionSign inLoading…
Discover
Related Assets
Healthcare
Related Articles
About Perrigo Company plc
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers. The company also offers healthy lifestyle products, such as smoking cessation and well-being products; skin care products consisting of dermatological care, scar management, lice treatment, and other products for various skin conditions; women's health products comprising feminine hygiene and contraceptives; vitamins, minerals, and supplements; and other miscellaneous self-care products. It sells its products under the Compeed, Dr. Fresh, Firefly, Good Sense, Good Start, Mederma, Nasonex, Plackers, Prevacid24HR, REACH, Rembrandt, Steripod, Opill, Solpadeine, Coldrex, Physiomer, NiQuitin, ACO, ellaOne, and Compeed brands. The company also offers contract manufacturing services. It sells its products through retail drug, supermarket, and mass merchandise chains; e-commerce stores; wholesalers; pharmacies; drug and grocery retailers; and para-pharmacies. The company was formerly known as Perrigo Company and changed its name to Perrigo Company plc in December 2013. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Location
Dublin, Ireland
Employees
8,100
Stock Market ROI Pro
All features, zero ads- web & app
Unlock every feature, ad-free, across our website and iOS app.
Perrigo Company plc (PRGO) stock trades at $13.65, down 0.07% on the day. With a market capitalization of $1.89 billion, PRGO is a small-cap healthcare stock. It trades at a forward P/E of 5.7 and earnings per share (EPS) of $-12.29. Over the most recent period the company reported a 3% year-over-year revenue decline and a net profit margin of -41.9%. Below you'll find PRGO's full fundamentals, fair-value estimates, dividend history, earnings and our buy, hold or avoid verdict for 2026.
PRGO - Frequently Asked Questions
Is Perrigo Company plc (PRGO) a good stock to buy in 2026?
Perrigo Company plc (PRGO) shows risks such as declining revenue (-3%), negative profit margins and high leverage (debt/equity of 138.2). Whether PRGO is a good buy in 2026 depends on your time horizon and risk tolerance - review the full bull case, bear case and fair-value estimates above. This is informational analysis, not financial advice.
What is PRGO's stock price today?
Perrigo Company plc (PRGO) trades at $13.65, down 0.07% on the session. Prices on this page update throughout the trading day.
Does PRGO pay a dividend?
Yes. Perrigo Company plc pays an annual dividend of $1.16 per share, a dividend yield of 8.49%. The most recent ex-dividend date was August 28, 2026. Its payout ratio is about 10950% of earnings.
What is PRGO's market cap?
Perrigo Company plc (PRGO) has a market capitalization of $1.89 billion, classifying it as a small-cap stock in the Healthcare sector.
Disclaimer: This page - including any buy/hold/avoid view, fair value or price estimate - is generated from market data for informational and educational purposes only and does not constitute financial, investment or trading advice. Data may be delayed or inaccurate. Always do your own research and consult a licensed financial advisor before making any investment decision.